Alejandra Bruna

Alejandra Bruna

UNVERIFIED PROFILE

Are you Alejandra Bruna?   Register this Author

Register author
Alejandra Bruna

Alejandra Bruna

Publications by authors named "Alejandra Bruna"

Are you Alejandra Bruna?   Register this Author

29Publications

922Reads

45Profile Views

MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.

Cell Res 2018 07 24;28(7):719-729. Epub 2018 May 24.

Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41422-018-0044-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028652PMC
July 2018

Modeling Breast Cancer Intertumor and Intratumor Heterogeneity Using Xenografts.

Cold Spring Harb Symp Quant Biol 2016 5;81:227-230. Epub 2017 Apr 5.

Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/sqb.2016.81.031112DOI Listing
February 2018

Computational approach to discriminate human and mouse sequences in patient-derived tumour xenografts.

BMC Genomics 2018 01 5;19(1):19. Epub 2018 Jan 5.

CRUK Cambridge Institute and Department of Oncology, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12864-017-4414-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755132PMC
January 2018

Patient-derived tumour xenografts for breast cancer drug discovery.

Endocr Relat Cancer 2016 12 4;23(12):T259-T270. Epub 2016 Oct 4.

Department of OncologyUniversity of Cambridge, Cambridge, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118939PMC
December 2016

A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.

Cell 2016 09 15;167(1):260-274.e22. Epub 2016 Sep 15.

Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge CB2 0RE, UK; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037319PMC
http://dx.doi.org/10.1016/j.cell.2016.08.041DOI Listing
September 2016

Context-Specific Effects of TGF-β/SMAD3 in Cancer Are Modulated by the Epigenome.

Cell Rep 2015 Dec 10;13(11):2480-2490. Epub 2015 Dec 10.

Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Cambridge CB2 0RE, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2015.11.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695334PMC
December 2015

Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.

Cancer Res 2015 Aug 15;75(15):2963-8. Epub 2015 Jul 15.

Breast Cancer Functional Genomics, Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge, Li Ka-Shing Centre, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-15-0727DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539570PMC
August 2015

Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

Nature 2015 Feb 26;518(7539):422-6. Epub 2014 Nov 26.

1] Department of Molecular Oncology, BC Cancer Agency, 675 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada [2] Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada [3] Michael Smith Genome Sciences Centre, Vancouver, British Columbia V5Z 1L3, Canada [4] Centre for Translational and Applied Genomics, BC Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature13952DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864027PMC
February 2015

Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids.

EMBO J 2003 Nov;22(22):6035-44

Institut de Recerca Biomèdica de Barcelona-Parc Científic de Barcelona (IRBB-PCB), Department of Bioquímica i Biologia Molecular, Universitat de Barcelona, E-08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/emboj/cdg590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC275446PMC
November 2003

Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis.

Neuropharmacology 2003 Oct;45(5):672-83

Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Universitat de Barcelona, Nucli Universitari de Pedralbes, 08028 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0028-3908(03)00204-1DOI Listing
October 2003